The Entacapone test is used to assess the levels of this medication in the blood serum and is an important part of managing Parkinson's disease. Entacapone is a catechol-O-methyltransferase (COMT) inhibitor primarily used to enhance the effectiveness of levodopa treatment, helping alleviate symptoms associated with the disease. This test is performed to monitor Entacapone levels in the blood to ensure the effectiveness of the treatment and minimize side effects. Maintaining the correct balance of drug levels is crucial for achieving optimal therapeutic outcomes. The test is also used to help doctors adjust dosages as needed based on the patient's response. The Entacapone test is a valuable tool in the care of Parkinson's patients, guiding treatment decisions and monitoring disease progression. It is recommended that results be interpreted by a healthcare professional to ensure appropriate treatment decisions.